The factor V Leiden mutation is a recently described autosomal dominant genetic risk factor for venous thromboembolism (VTE). Persons who are heterozygous or homozygous for this disorder are at 4 to 7 times and 50 to 100 times increased risk, respectively, for VTE. In particular, women have ...
Factor V Leiden 第五凝血因子；莱登第五因子 第五凝血因子 检验第五凝血因子(Factor V leiden)上的G1691A突变：造成容易产生血栓的体质(血栓病, thrombophilia)。北美洲有 5% 的人遗传有莱登第五因子 ( Factor V Leiden )﹐影响凝血功能。 年长﹑肥胖﹑抽烟﹐与及曾经出现过静脉栓塞症状的人士﹐再次...
(redirected fromFactor V Leiden mutation) Thesaurus Medical Legal Acronyms Encyclopedia mu·ta·tion (myo͞o-tā′shən) n. 1.The act or process of being altered or changed. 2.An alteration or change, as in nature, form, or quality. ...
Factor V Leiden Mutation: What Is It? What Are the Implications for Cl inical Practice? American Journal for Nurse PractitionersFoster, Christine
The meaning of FACTOR V LEIDEN is a point mutation producing an abnormal version of factor V that is resistant to inactivation and causes prolonged clotting of blood.
Clinical Significance:This test detects the factor V Leiden variant, the most common cause of inherited thrombophilia; it may be used to evaluate individuals with a strong personal or family history of venous thromboembolism (VTE) and inform treatment or preventive decisions [1]. ...
遗传阻断导读:Factor V Leiden易栓症是一种儿科疾病。佳学基因对Factor V Leiden易栓症的发生进行了基因解码,并将之收入《人的基因序列变化与人体疾病表征》中,便于医生选择和使用,进行Factor V Leiden易栓症遗传阻断,也便于患者更好地进行治疗和健康管理。
intensity the energy intensity cannot be used to quantify specific environmental pressures (e.g. ozone depletion) rather than a generic pressure (Source:LeidenUniversity). switch-china-sme.eu switch-china-sme.eu 与物质强 度相似,能量强度不可以用于对具体的环境压力进行 定量(例如臭氧消耗),它更多地应...
THE LEIDEN MUTATION OF THE FACTOR V GENE IN PREECLAMPSIA AND ECLAMPSIA 研究目的:以分子遺傳研究, 探討第五因子基因(Factor V gene)之來登突變 (Leiden mutation)與重度子癇前症/子癇症的相關.研究方法: 收集 105 位重度子癇前症/子癇症的... FM Chang 被引量: 0发表: 0年 The factor V Leiden ...
BACKGROUND AND PURPOSE: Resistance to activated protein C is a common inherited risk factor for venous thrombosis, which is due to a mutation in coagulation factor V (factor V Leiden mutation). It is present in approximately 20% of unselected consecutive patients with deep vein thrombosis. The ...